Search results for PX-TA1129

Golimumab Biosimilar – Anti-TNFA, TNF alpha mAb – Research Grade, ProteoGenix, PX-TA1129

Description of Golimumab Biosimilar - Anti-TNFA, TNF alpha mAb - Research Grade General information on Anti-TNFA/TNF alpha(Homo sapiens) (Golimumab) Monoclonal Antibody Golimumab is a human IgG1 alpha monoclonal antibody, developped from genetically engineered mice immunized with human TNFalpha. Golimumab binds to and inhibits soluble and transmembrane human TNFalpha. Elevated TNFalpha is related to chronic inflammation. Therefore, golimumab can be used in adults,for the treatment of active rheumatoid arthritis (RA), active psoriatic arthritis ( PsA), active ankylosing spondylitis (AS), ulcerative colitis (UC). In the United States and Canada, golimumab is sold under the Simponi® brand. The FDA label includes a black box that warns of serious infections and malignant tumors.